InvestorsHub Logo
Followers 287
Posts 48619
Boards Moderated 15
Alias Born 08/19/2009

Re: TheFinalCD post# 11

Thursday, 11/04/2021 11:45:03 AM

Thursday, November 04, 2021 11:45:03 AM

Post# of 55

Looks like a StockTwits pump!

We know how those end up!

Sounds like old misinformation swirling!

The agreement will evaluate the combination of Evaxion’s cancer immunotherapy EVX-01 with Merck's anti-PD-1 therapy Keytruda (pembrolizumab).

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVAX News